NCT05267106 · Interventional trial
Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations
Overall registry status Terminated
Phase 2
Conditions Adult-type Diffuse Gliomas, Glioblastoma
Delaware Valley sites
- University of Pennsylvania Hospital · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory